Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Current Leases (2018 - 2026)

Champions Oncology has reported Current Leases over the past 9 years, most recently at $1.5 million for Q1 2026.

  • For Q1 2026, Current Leases rose 6.62% year-over-year to $1.5 million; the TTM value through Jan 2026 reached $1.5 million, up 6.62%, while the annual FY2025 figure was $1.5 million, 10.02% up from the prior year.
  • Current Leases for Q1 2026 was $1.5 million at Champions Oncology, roughly flat from $1.5 million in the prior quarter.
  • Over five years, Current Leases peaked at $1.5 million in Q1 2026 and troughed at $1.0 million in Q1 2022.
  • A 5-year average of $1.3 million and a median of $1.3 million in 2024 define the central range for Current Leases.
  • Biggest five-year swings in Current Leases: increased 28.69% in 2022 and later grew 6.62% in 2026.
  • Year by year, Current Leases stood at $1.1 million in 2022, then increased by 12.53% to $1.3 million in 2023, then grew by 9.88% to $1.4 million in 2024, then increased by 8.85% to $1.5 million in 2025, then grew by 0.26% to $1.5 million in 2026.
  • Business Quant data shows Current Leases for CSBR at $1.5 million in Q1 2026, $1.5 million in Q4 2025, and $1.5 million in Q3 2025.